Parallel Advisors, LLC Aerie Pharmaceuticals Inc Transaction History

Parallel Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$6.37 - $15.23 $50 - $121	8 New	8 $0
Q1 2022 Apr 28, 2022	SELL	$5.64 - $9.8 $0 - $0	0 Closed	0 $0
Q4 2021 Jan 20, 2022	SELL	$7.02 - $13.33 $2,120 - $4,025	-302 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$11.32 - $16.63 $3,418 - $5,022	302 New	302 $3,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.